Gaush Meditech Balance Sheet Health
Financial Health criteria checks 5/6
Gaush Meditech has a total shareholder equity of CN¥1.6B and total debt of CN¥568.2M, which brings its debt-to-equity ratio to 36.5%. Its total assets and total liabilities are CN¥2.8B and CN¥1.3B respectively. Gaush Meditech's EBIT is CN¥171.4M making its interest coverage ratio 4.1. It has cash and short-term investments of CN¥754.2M.
Key information
36.5%
Debt to equity ratio
CN¥568.16m
Debt
| Interest coverage ratio | 4.1x |
| Cash | CN¥754.20m |
| Equity | CN¥1.56b |
| Total liabilities | CN¥1.25b |
| Total assets | CN¥2.81b |
Recent financial health updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Recent updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot
Jul 19Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital
Jul 16Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Jun 19We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive
Apr 05Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)
Dec 07A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)
Aug 08Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry
Jun 01Financial Position Analysis
Short Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥740.1M).
Long Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥511.8M).
Debt to Equity History and Analysis
Debt Level: 2407 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2407's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 2407's debt is well covered by operating cash flow (22.4%).
Interest Coverage: 2407's interest payments on its debt are well covered by EBIT (4.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:19 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Gaush Meditech Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Youjue Hu | Morgan Stanley |